Multidrug Transporters CaCdr1p and CaMdr1p of Candida albicans Display Different Lipid Specificities: both Ergosterol and Sphingolipids Are Essential for Targeting of CaCdr1p to Membrane Rafts
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
In this study, we compared the effects of altered membrane lipid composition on the localization of two membrane drug transporters from different superfamilies of the pathogenic yeast Candida albicans . We demonstrated that in comparison to the major facilitator superfamily multidrug transporter CaMdr1p, ATP-binding cassette transporter CaCdr1p of C. albicans is preferentially localized within detergent-resistant membrane (DRM) microdomains called ‘rafts.’ Both CaCdr1p and CaMdr1p were overexpressed as green fluorescent protein (GFP)-tagged proteins in a heterologous host Saccharomyces cerevisiae , wherein either sphingolipid (Δ sur4 or Δ fen1 or Δ ipt1 ) or ergosterol (Δ erg24 or Δ erg6 or Δ erg4 ) biosynthesis was compromised. CaCdr1p-GFP, when expressed in the above mutant backgrounds, was not correctly targeted to plasma membranes (PM), which also resulted in severely impaired drug resistance. In contrast, CaMdr1p-GFP displayed no sorting defect in the mutant background and remained properly surface localized and displayed no change in drug resistance. Our data clearly show that CaCdr1p is selectively recruited, over CaMdr1p, to the DRM microdomains of the yeast PM and that any imbalance in the raft lipid constituents results in missorting of CaCdr1p.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The function of these proteins is consistent with the role that lipid rafts play in many biological processes, such as lipid metabolism, cell wall biogenesis, protein metabolism, electron transport, ATP synthesis and cellular stress.”
From The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn (2016) · cites this paper as [67]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A total of 29 proteins were identi fi ed, including PMA1 (the marker for lipid rafts in S. cerevisiae ) , ECM33 (glycosylphosphatidylinositol (GPI)anchored protein involved in cell wall biogenesis), MNN7 , PMT2 , MNT1 (mannosyltransferases), ERG11 , SCS7 (proteins involved in lipid metabolism), SSA1 , HSP90 (heat shock proteins) and, CDR1 (the ATP-binding cassette (ABC) multidrug transporter).”
From The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn (2016) · cites this paper as [67]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New heterologous modules for classical or PCR‐based gene disruptions in Saccharomyces cerevisiae
Wach, A., Brachat, A., Pöhlmann, R., & Philippsen, P. (1994) · Yeast · doi:10.1002/yea.320101310 · Cited by 2,531 · cited 2×
“The knockout was based on a PCR-generated deletion strategy, which was used to systematically replace the yeast open reading frame (ORF) from its start to stop codon with a kanMX4 module (5, 45).”
MethodStudies on the transformation of intact yeast cells by the LiAc/SS‐DNA/PEG procedure
Gietz, R. D., Schiestl, R. H., Willems, A. R., & Woods, R. A. (1995) · Yeast · doi:10.1002/yea.320110408 · Cited by 2,030 · cited 3×
“1E), and the amplicon was purified and transformed by the lithium acetate transformation protocol (18).”
MethodA simple and efficient method for direct gene deletion in Saccharomyces cerevisiae
Baudin, A., Ozier-Kalogeropoulos, O., Denouel, A., Lacroute, F., & Cullin, C. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.14.3329 · Cited by 1,269 · cited 2×
“The knockout was based on a PCR-generated deletion strategy, which was used to systematically replace the yeast open reading frame (ORF) from its start to stop codon with a kanMX4 module (5, 45).”
MethodResistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
Sanglard, D., & Odds, F. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00181-0 · Cited by 784 · cited 1×
“Point mutations or overexpression of the drug target, a decrease in the import of drugs, and an enhanced efflux of drugs are some of the strategies employed by drugresistant yeast to overcome the lethal effects of the drugs (4, 8, 39, 40).”
BackgroundLipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast
Bagnat, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060034697 · Cited by 574 · cited 8×
“(2), with the following modification: crude membranes, instead”
BackgroundMethodInfluentialLipid Rafts in Higher Plant Cells
Mongrand, S., Morel, J., Laroche, J., Claverol, S., Carde, J.-P., Hartmann, M.-A., Bonneu, M., Simon-Plas, F., Lessire, R., & Bessoule, J.-J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403440200 · Cited by 477
Complete inventory of the yeast ABC proteins
Decottignies, A., & Goffeau, A. (1997) · Nature Genetics · doi:10.1038/ng0297-137 · Cited by 454 · cited 1×
“Genome analysis of Saccharomyces cerevisiae and of the pathogenic yeast Candida albicans reveal the existence of 30 and 28 putative ABC transporters, respectively, of which only a few function as drug transporters (9, 17).”
BackgroundLipid-dependent Targeting of G Proteins into Rafts
Moffett, S., Brown, D. A., & Linder, M. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.2191 · Cited by 429 · cited 1×
“The presence of the microdomains, also called ‘lipid rafts,’ in various organisms plays an important role in cell signaling, protein sorting, and virulence (13, 29, 30, 31, 36, 47).”
BackgroundATPase and Multidrug Transport Activities of the Overexpressed Yeast ABC Protein Yor1p
Decottignies, A., Grant, A. M., Nichols, J. W., de Wet, H., McIntosh, D. B., & Goffeau, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12612 · Cited by 382 · cited 12×
“In order to critically evaluate the role of the DRM lipid constituents in the localization of the efflux pumps, in this study, we have overexpressed green fluorescent protein (GFP)-tagged CaCdr1p and CaMdr1p in different lipid mutant backgrounds of S. cerevisiae.”
BackgroundInfluentialA Human-Curated Annotation of the Candida albicans Genome
Braun, B. R., van het Hoog, M., d'Enfert, C., Martchenko, M., Dungan, J., Kuo, A., Inglis, D. O., Uhl, M. A., Hogues, H., Berriman, M., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010001 · Cited by 342 · cited 2×
“albicans, out of 71 MFS proteins, only CaMDR1 is known to extrude drugs, where its overexpression has been linked to azole resistance (6, 35).”
Background
Cited by
Structures and General Transport Mechanisms by the Major Facilitator Superfamily (MFS)
Drew, D., North, R. A., Nagarathinam, K., & Tanabe, M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00983 · Cited by 465
Antifungal Peptides as Therapeutic Agents
Fernández de Ullivarri, M., Arbulu, S., Garcia-Gutierrez, E., & Cotter, P. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00105 · Cited by 264
Yeast ATP-Binding Cassette Transporters Conferring Multidrug Resistance
Prasad, R., & Goffeau, A. (2012) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092611-150111 · Cited by 221
Self-citationAntifungal peptides: To be or not to be membrane active
Rautenbach, M., Troskie, A. M., & Vosloo, J. A. (2016) · Biochimie · doi:10.1016/j.biochi.2016.05.013 · Cited by 202
Shih, P.-Y., Liao, Y.-T., Tseng, Y.-K., Deng, F.-S., & Lin, C.-H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00602 · Cited by 156
Plasma membrane lipids and their role in fungal virulence
Rella, A., Farnoud, A. M., & Del Poeta, M. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.11.003 · Cited by 149
“In addition, defects in various genes encoding ergosterol or sphingolipid biosynthesis resulted in the defective transfer of Cdr1p to the plasma membrane suggesting that sphingolipids and sterols, and likely lipid microdomains, play a role in the transfer of drug efflux pumps to the plasma membrane[77].”
BackgroundThe negative cofactor 2 complex is a key regulator of drug resistance in Aspergillus fumigatus
Furukawa, T., van Rhijn, N., Fraczek, M., Gsaller, F., Davies, E., Carr, P., Gago, S., Fortune-Grant, R., Rahman, S., Gilsenan, J. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14191-1 · Cited by 139
Mecanismos de resistencia a los antifúngicos: levaduras y hongos filamentosos
Espinel‐Ingroff, A. (2008) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(08)70027-5 · Cited by 183
Lv, Q.-Z., Yan, L., & Jiang, Y.-Y. (2016) · Virulence · doi:10.1080/21505594.2016.1188236 · Cited by 133
Lattif, A. A., Mukherjee, P. K., Chandra, J., Roth, M. R., Welti, R., Rouabhia, M., & Ghannoum, M. A. (2011) · Microbiology · doi:10.1099/mic.0.051086-0 · Cited by 128
“In this regard, lipid rafts have been proposed to play important roles in polarization and compartmentalization of the plasma membrane (Wachtler & Balasubramanian, 2006), surface transport of plasma membrane ATPase (Toulmay & Schneiter, 2007), hyphal growth (Martin & Konopka, 2004), drug resistance (Hallstrom et al.,…”
BackgroundThe ABCs of Candida albicans multidrug transporter Cdr1
Prasad, R., Banerjee, A., Khandelwal, N. K., & Dhamgaye, S. (2015) · Eukaryotic Cell · doi:10.1128/ec.00137-15 · Cited by 123
Self-citationVandeputte, P., Tronchin, G., Larcher, G., Ernoult, E., Bergès, T., Chabasse, D., & Bouchara, J.-P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00423-08 · Cited by 117
“(25) demonstrated that deletion of the ERG6 gene increases susceptibility to azoles, probably due to the mistargeting of Cdr1p to the plasma membrane, resulting in a loss of the efflux function of this protein.”
BackgroundAbnormal Ergosterol Biosynthesis Activates Transcriptional Responses to Antifungal Azoles
Hu, C., Zhou, M., Wang, W., Sun, X., Yarden, O., & Li, S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00009 · Cited by 114
“In C. albicans, Cdr1p, the homolog of CDR4, prefers to be localized in lipid rafts which enrich in sterols and phospholipids (Pasrija et al., 2008).”
BackgroundThomas, E., Roman, E., Claypool, S., Manzoor, N., Pla, J., & Panwar, S. L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00889-13 · Cited by 105
“Mutants defective in either of the pathways display reduce PM localization and reduced efflux activity of Cdr1p, leading to increased susceptibility to azoles (45, 83).”
BackgroundSelf-citationAnalysis of sphingolipids, sterols, and phospholipids in human pathogenic Cryptococcus strains
Singh, A., MacKenzie, A., Girnun, G., & Del Poeta, M. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m078600 · Cited by 85
“gattii strains (R265 and R272) are the most well-studied (1, 5), but little is known about their lipid profiles (19, 20, 47).”
BackgroundYeast metabolic engineering – Targeting sterol metabolism and terpenoid formation
Wriessnegger, T., & Pichler, H. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.03.001 · Cited by 91
Singh, S., Fatima, Z., Ahmad, K., & Hameed, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203079 · Cited by 90
Singh, A., Yadav, V., & Prasad, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039812 · Cited by 72
“Accordingly, clinical azole resistant isolates of C. albicans display transcriptional activation of genes, encoding ATP Binding Cassette (ABC) multidrug transporter proteins CaCdr1p or CaCdr2p or Major Facilitator Super family (MFS) efflux pump protein CaMdr1p [5– 8].”
BackgroundInfluentialSelf-citationGodinho, C. P., Prata, C. S., Pinto, S. N., Cardoso, C. L., Bandarra, N. M., Fernandes, F., & Sá‐Correia, I. (2018) · Scientific Reports · doi:10.1038/s41598-018-26128-7 · Cited by 83
Engineering Saccharomyces cerevisiae Coculture Platform for the Production of Flavonoids
Du, Y., Yang, B., Yi, Z., Hu, L., & Li, M. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b07916 · Cited by 71
Sun, L.-M., Liao, K., Liang, S., Yu, P.-H., & Wang, D.-Y. (2015) · Journal of Applied Microbiology · doi:10.1111/jam.12737 · Cited by 67
“albicans probably resides in these microdomains and any perturbation to the lipid raft constituents affects its positioning and functionality (Pasrija et al. 2008).”
BackgroundInfluentialLipid raft involvement in yeast cell growth and death
Mollinedo, F. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00140 · Cited by 66
“…metabolism of major raft components (ergosterol and ceramide; Insenser et al., 2006); Rta2p, a translocase that moves sphingolipid long chain bases from the inside to the outside membrane (Wang et al., 2012); and the ATP-binding cassette (ABC) multidrug transporter CaCdr1p (Pasrija et al., 2008).”
BackgroundSphingolipid Biosynthetic Pathway Genes FEN1 and SUR4 Modulate Amphotericin B Resistance
Sharma, S., Alfatah, Bari, V. K., Rawal, Y., Paul, S., & Ganesan, K. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02130-13 · Cited by 66
Shah, A. H., Singh, A., Dhamgaye, S., Chauhan, N., Vandeputte, P., Suneetha, K. J., Kaur, R., Mukherjee, P. K., Chandra, J., Ghannoum, M. A., et al. (2014) · Biochemical Journal · doi:10.1042/bj20140010 · Cited by 64
Self-citationErgosterol Biosynthesis and Regulation Impact the Antifungal Resistance and Virulence of Candida spp
Eliaš, D., Tóth Hervay, N., & Gbelská, Y. (2024) · Stresses · doi:10.3390/stresses4040041 · Cited by 63
“This fact points to different lipid specificities of the multidrug transporters in C. albicans [111].”
Khandelwal, N. K., Chauhan, N., Sarkar, P., Esquivel, B. D., Coccetti, P., Singh, A., Coste, A. T., Gupta, M., Sanglard, D., White, T. C., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.807032 · Cited by 59
“albicans, the PM-bound transporter Cdr1 has been shown to be specifically localized within the raft region (15), and any imbalance in raft lipid constituents, such as sphingolipids or ergosterol, results in altered drug susceptibility (16).”
BackgroundSelf-citationThe yeast sphingolipid signaling landscape
Montefusco, D. J., Matmati, N., & Hannun, Y. A. (2013) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2013.10.006 · Cited by 66
“albicans showed multidrug sensitivity phenotypes attributed to improper localization of the membrane channel Cdr1 (Pasrija et al., 2008).”
BackgroundInfluentialPadovan, A. C. B., Rocha, W. P. D. S., Toti, A. C. D. M., de Jesus, D. F. F., Chaves, G. M., & Colombo, A. L. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103267 · Cited by 60
Phospholipidome of Candida : Each Species of Candida Has Distinctive Phospholipid Molecular Species
Singh, A., Prasad, T., Kapoor, K., Mandal, A., Roth, M. R., Welti, R., & Prasad, R. (2010) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2010.0041 · Cited by 61
“Indeed, the drug susceptibility phenotype of Candida appears to result from interplay among drug diffusion, drug extrusion, and the membrane lipid environment (Mukhopadhyay et al., 2004; Pasrija et al., 2005, 2008).”
Self-citationSingh, A., & Prasad, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019266 · Cited by 51
“Notably, overexpression of either CaCdr1p or CaMdr1p efflux pump proteins led to a different lipidomic response among AR isolates.”
BackgroundSelf-citationRaft-Like Membrane Domains in Pathogenic Microorganisms
(2015) · Current Topics in Membranes · doi:10.1016/bs.ctm.2015.03.005 · Cited by 51
Fluconazole resistance in Candida albicans is induced by Pseudomonas aeruginosa quorum sensing
Bandara, N., Wood, D., Vanwonterghem, I., Hugenholtz, P., Cheung, B. P. K., & Samaranayake, L. P. (2020) · Scientific Reports · doi:10.1038/s41598-020-64761-3 · Cited by 58
Unraveling the role of membrane microdomains during microbial infections
Bagam, P., Singh, D. P., Inda, M. E., & Batra, S. (2017) · Cell Biology and Toxicology · doi:10.1007/s10565-017-9386-9 · Cited by 50
“1974; Pasrija et al.”
BackgroundInfluentialLipids of Candida albicans and their role in multidrug resistance
Prasad, R., & Singh, A. (2013) · Current Genetics · doi:10.1007/s00294-013-0402-1 · Cited by 48
“albicans as detergent resistant fractions (DRM) of the PM (Pasrija et al. 2008).”
BackgroundSelf-citationWhaley, S. G., Tsao, S., Weber, S., Zhang, Q., Barker, K. S., Raymond, M., & Rogers, P. D. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00732-16 · Cited by 41
“also displayed a punctate distribution pattern, suggesting an association with lipid rafts, as 231 previously shown for Cdr1p (25).”
Suchodolski, J., Muraszko, J., Korba, A., Bernat, P., & Krasowska, A. (2019) · Yeast · doi:10.1002/yea.3455 · Cited by 47
“Cdr1p-GFP localized properly into PMs in most CAF2-1 cells, most likely because fluconazole–gentamicin treatment leads to overproduction of ergosterol in the CAF2-1 strain (Table 3), which is crucial for proper Cdr1p localization (Pasrija et al., 2008).”
BackgroundSphingolipids: Regulators of azole drug resistance and fungal pathogenicity
Song, J., Xiao, L., & Li, R. (2020) · Molecular Microbiology · doi:10.1111/mmi.14586 · Cited by 40
“…Cdr1 was poorly localized and the efflux of azole drugs was severely hampered in Candida cells (Mukhopadhyay et al., 2004; Prasad et al., 2005; Pasrija et al., 2008; Suchodolski et al., 2020), indicating that membrane sphingolipid–ergosterol interactions are required for surface localization…”
BackgroundKaranja, C. W., Hong, W., Younis, W., Eldesouky, H. E., Seleem, M. N., & Cheng, J. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01798 · Cited by 38
Puri, N., Prakash, O., Manoharlal, R., Sharma, M., Ghosh, I., & Prasad, R. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.07.050 · Cited by 37
Self-citationSynergistic mechanisms of retigeric acid B and azoles against Candida albicans
Sun, L., Cheng, A., Wu, X. Z., Zhang, H. J., & Lou, H. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2009.04429.x · Cited by 32
“Besides, overexpression of the ERG11 gene encoding lanosterol 14a-demethylase, a target for azole antifungals and alteration of the target structure (Erg11p) also account for the resistance (Mukherjee et al. 2003; Kohli et al. 2002; Pasrija et al. 2008).”
BackgroundRen, B., Dai, H., Pei, G., Tong, Y., Zhuo, Y., Yang, N., Su, M.-Y., Huang, P., Yang, Y., & Zhang, L. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5425-5 · Cited by 37
Pais, P., Califórnia, R., Galocha, M., Viana, R., Ola, M., Cavalheiro, M., Takahashi‐Nakaguchi, A., Chibana, H., Butler, G., & Teixeira, M. C. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00554-20 · Cited by 39
Lipidomics and in Vitro Azole Resistance in Candida albicans
Singh, A., Mahto, K. K., & Prasad, R. (2013) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2012.0075 · Cited by 34
“These rafts not only provide a localization platform for membrane proteins but serve as an important signaling component as well (Pasrija et al., 2008).”
InfluentialSelf-citationWang, H., Ji, Z., Feng, Y., Yan, T., Cao, Y., Lu, H., & Jiang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1101553 · Cited by 30
“It is reported that ergosterol and sphingolipid contents can affect the membrane localization of Cdr1 (Pasrija et al., 2008).”
BackgroundInfluentialAntifungal membranolytic activity of the tyrocidines against filamentous plant fungi
Rautenbach, M., Troskie, A. M., Vosloo, J. A., & Dathe, M. (2016) · Biochimie · doi:10.1016/j.biochi.2016.06.008 · Cited by 34
Membrane homoeostasis and multidrug resistance in yeast
Panwar, S. L., Pasrija, R., & Prasad, R. (2008) · Bioscience Reports · doi:10.1042/bsr20080071 · Cited by 32
Self-citationXu, T., Tripathi, S., Feng, Q. F., Lorenz, M. C., Wright, M., Jacob, M. R., Mask, M. M., Baerson, S. R., Li, X., Clark, A. M., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05663-11 · Cited by 30
“In addition, Cdr1 localization to the plasma membrane was disrupted when it was expressed in yeast cells defective either in the ergosterol or in the sphingolipid biosynthesis pathway (35).”
BackgroundPasricha, S., Payne, M., Cánovas, D., Pase, L. B., Kosoltanapiwat, N., Beard, S., Oshlack, A., Smyth, G. K., Chaiyaroj, S. C., Boyce, K. J., et al. (2013) · G3 Genes Genomes Genetics · doi:10.1534/g3.113.006809 · Cited by 29
“Lipid rafts allow the stable association of membrane-bound proteins to the cell surface, thus ergosterol production has been linked to many important cellular functions from nutrient uptake and drug efflux to polarity determination (Alvarez et al. 2007; Iwaki et al. 2008; Pasrija et al. 2008).”
BackgroundYadav, B., Bhatnagar, S., Ahmad, M. F., Jain, P., Pratyusha, V. A., Kumar, P., & Komath, S. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.528802 · Cited by 27
“Furthermore, membrane integrity and composition are not only essential for the viability of the fungal cells but also influence the localization and functioning of several membrane-localized proteins (38, 39).”
Júnior, L. R. B., Gast, C. E., Mao, Y., & Wong, B. (2010) · Eukaryotic Cell · doi:10.1128/ec.00355-09 · Cited by 36
“cerevisiae increased cycloheximide MICs (20, 38), but cycloheximide did not inhibit [(3)H]fluconazole transport by PGVs isolated from MDR1-overexpressing C.”
BackgroundUrbanek, A. K., Muraszko, J., Derkacz, D., Łukaszewicz, M., Bernat, P., & Krasowska, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179975 · Cited by 30
“[18] used 30% Optipreptm in their study.”
BackgroundVandenbosch, D., Bink, A., Govaert, G., Cammue, B. P. A., Nelis, H. J. C. F., Thevissen, K., & Coenye, T. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05106-11 · Cited by 22
“Other studies have suggested a role for sphingolipids in governing miconazole resistance in planktonic yeast cultures (11, 21), and in the present study, we focused on the role of sphingolipid biosynthesis in the molecular mechanisms underlying the resistance of C.”
BackgroundKonecna, A., Hervay, N. T., Valachovič, M., & Gbelská, Y. (2016) · Yeast · doi:10.1002/yea.3212 · Cited by 25
“Pasrija et al. (2008) demonstrated that deletion of the ERG6 gene increases susceptibility of C. albicans to azoles, probably owing to the mistargeting of Cdr1p to the plasma membrane, resulting in a loss of the efflux function of this protein.”
BackgroundSphingolipids from the human fungal pathogen Aspergillus fumigatus
Fontaine, T. (2017) · Biochimie · doi:10.1016/j.biochi.2017.06.012 · Cited by 24
Wang, Y., Wang, M., Xu, L., Sun, Y., & Feng, J. (2020) · Plant Disease · doi:10.1094/pdis-11-19-2478-re · Cited by 21
Tsao, S., Weber, S., Cameron, C. A., Nehme, D., Ahmadzadeh, E., & Raymond, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw252 · Cited by 25
Sphingolipid Signaling in Fungal Pathogens
Rhome, R. M., & Poeta, M. D. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6741-1_16 · Cited by 23
Mechanisms of Azole Potentiation: Insights from Drug Repurposing Approaches
Xiong, J., Lu, H., & Jiang, Y. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00657 · Cited by 20
Zande, P. V., Gautier, C., Kawar, N., Maufrais, C., Metzner, K., Wash, E., Beach, A. K., Bracken, R., Maciel, E. I., de Sá, N. P., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012497 · Cited by 23
Learning the ABC of oral fungal drug resistance
Cannon, R. D., & Holmes, A. R. (2015) · Molecular Oral Microbiology · doi:10.1111/omi.12109 · Cited by 24
Differential dynamics of membrane proteins in yeast
Ganguly, S., Singh, P., Manoharlal, R., Prasad, R., & Chattopadhyay, A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.054 · Cited by 20
“Interestingly, Cdr1p has been reported to be localized in ergosterol/sphingolipid rich detergent resistant microdomains of plasma membrane and modulation in ergosterol or sphingolipid may compromise its sorting and localization [26].”
BackgroundSelf-citationEstimation of Candida albicans ABC Transporter Behavior in Real-Time via Fluorescence
Szczepaniak, J., Łukaszewicz, M., & Krasowska, A. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01382 · Cited by 20
“Similar effects were observed in the S. cerevisiae strain expressing C. albicans CDR1 with deletions in the genes involved in ergosterol synthesis (Pasrija et al., 2008).”
LAM Genes Contribute to Environmental Stress Tolerance but Sensibilize Yeast Cells to Azoles
Соколов, С. С., Vorobeva, M. A., Smirnova, A. I., Smirnova, E. A., Trushina, N. I., Galkina, K. V., Severin, F. F., & Кнорре, Д. А. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00038 · Cited by 25
Hans, S., Fatima, Z., & Hameed, S. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.07.003 · Cited by 21
A Proteomic Landscape of Candida albicans in the Stepwise Evolution to Fluconazole Resistance
Song, N., Zhou, X., Li, D., Li, X., & Liu, W. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02105-21 · Cited by 17
“Molecular function Catalytic activity 51 (59) 101 (57) 31 (58) 43 (50) Binding 23 (27) 59 (33) 19 (36) 28 (33) Transporter activity 6 (7) 11 (6) 2 (4) 9 (11) Proteomics of Serial Candida albicans Isolates Antimicrobial Agents and Chemotherapy”
BackgroundSphingolipid diversity in Candida auris: unraveling interclade and drug resistance fingerprints
Ali, B., Kumar, M., Kumar, P., Chauhan, A., Usmani, S. A., Rudramurthy, S. M., Meis, J. F. G. M., Chakrabarti, A., Singh, A., Gaur, N. A., et al. (2024) · FEMS Yeast Research · doi:10.1093/femsyr/foae008 · Cited by 21
Self-citationSgherri, C., Porta, A., Castellano, S., Pinzino, C., Quartacci, M. F., & Calucci, L. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.10.015 · Cited by 16
Nagayoshi, Y., Miyazaki, T., Shimamura, S., Nakayama, H., Minematsu, A., Yamauchi, S., Takazono, T., Nakamura, S., Yanagihara, K., Kohno, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180990 · Cited by 19
“albicans, Cdr1 plays a role in maintaining membrane asymmetry and alterations in membrane lipid composition affects Cdr1 functions [28,29].”
BackgroundMota, M. N., Matos, M., Bahri, N., & Sá‐Correia, I. (2024) · Microbial Cell Factories · doi:10.1186/s12934-024-02309-0 · Cited by 18
“This new information for butyric and octanoic acids is very useful to guide a system biology approach to yeasts of bio-technological relevance to obtain more robust strains for implementation of economically and technologically sustainable bioprocesses towards a circular bio-based economy.”
BackgroundSun, L. M., Lv, B., Cheng, A. X., Wu, X. Z., & Lou, H. X. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.36 · Cited by 15
RetractedVela-Corcia, D., Hierrezuelo, J., Pérez-Lorente, A. I., Stincone, P., Pakkir Shah, A. K., Grélard, A., Zi-Long, Y., de Vicente, A., Pérez García, A., Bai, L., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06947-3 · Cited by 13
“Methotrexateand fl uconazolearetwomoleculesthatdeplete Pma1 in S. cerevisiae , compromising ion transport and the in fl ux of nutrients 29,45 .”
BackgroundProtonophore FCCP provides fitness advantage to PDR-deficient yeast cells
Galkina, K. V., Finkelberg, J. M., Маркова, О. В., Azbarova, A. V., Banerjee, A., Kumari, S., Соколов, С. С., Severin, F. F., Prasad, R., & Кнорре, Д. А. (2020) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-020-09849-1 · Cited by 15
Self-citationMechanisms of Drug Resistance in Fungi and Their Significance in Biofilms
Prasad, R., Shah, A. H., & Dhamgaye, S. (2014) · Springer series on biofilms · doi:10.1007/978-3-642-53833-9_4 · Cited by 14
Self-citationPhospholipid biosynthesis disruption renders the yeast cells sensitive to antifungals
Kundu, D., Hameed, S., Fatima, Z., & Pasrija, R. (2019) · Folia Microbiologica · doi:10.1007/s12223-019-00713-3 · Cited by 14
Self-citationCzolkoss, S., Safronov, X., Rexroth, S., Knoke, L. R., Aktas, M., & Narberhaus, F. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.754486 · Cited by 13
Shahi, G., Kumar, M., Khandelwal, N., Banerjee, A., Sarkar, P., Kumari, S., Esquivel, B. D., Chauhan, N., Chattopadhyay, A., White, T. C., et al. (2022) · Journal of Fungi · doi:10.3390/jof8070651 · Cited by 12
Self-citationAntifungal Targets, Mechanisms of Action, and Resistance in Candida albicans
Akins, R. A., & Sobel, J. D. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-180-2_29 · Cited by 15
Lu, Y., Zhou, Z., Mo, L., Guo, Q., Peng, X., Hu, T., Zhou, X., Ren, B., & Xu, X. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09960-3 · Cited by 13
The sphingolipid inhibitor myriocin increases Candida auris susceptibility to amphotericin B
Stieber, H., Junghanns, L., Wilhelm, H., Batliner, M., Aldejohann, A. M., Kurzai, O., & Martin, R. (2024) · Mycoses · doi:10.1111/myc.13723 · Cited by 13
“21 23–26 Such disruptions of the sphingolipid imbalance can also lead to a mis-sorting of the efflux pump Cdr1 in the cell membranes of C . albicans which correlates with increased azole sensitivity.”
BackgroundPanapruksachat, S., Iwatani, S., Oura, T., Vanittanakom, N., Chindamporn, A., Niimi, K., Niimi, M., Lamping, E., Cannon, R. D., & Kajiwara, S. (2016) · Medical Mycology · doi:10.1093/mmy/myv117 · Cited by 11
Jacko, J., Morvová, M., Hervay, N. T., Eliaš, D., Gbelská, Y., Waczulíková, I., Gášková, D., Balážová, M., & Šikurová, L. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01599-w · Cited by 11
“On the other hand, [20] documented that mutations in the ERG6 gene increases the ef fi cacy of polyenes against C. albicans and [21] demonstrated that deletion of the ERG6 gene increases susceptibility to azoles.”
A homologous overexpression system to study roles of drug transporters in Candida glabrata
Kumari, S., Kumar, M., Khandelwal, N., Pandey, A. K., Bhakt, P., Kaur, R., Prasad, R., & Gaur, N. A. (2020) · FEMS Yeast Research · doi:10.1093/femsyr/foaa032 · Cited by 9
Self-citationHans, S., Fatima, Z., & Hameed, S. (2021) · BioMetals · doi:10.1007/s10534-020-00282-w · Cited by 9
Fatima, T., Fatima, Z., & Hameed, S. (2023) · International Microbiology · doi:10.1007/s10123-023-00343-3 · Cited by 9
“…hypothesise that impaired efflux activity of ABC transporters could be due to lowering in ergosterol content as ABC transporters are known to preferentially localize in lipid raft regions which are rich in ergosterol (Pasrija et al. 2008) and we observed depleted ergosterol in the current study.”
BackgroundWang, H., Zhang, Y., Wang, J., Chen, Y., Hou, T., Zhao, Y. F., & Ma, Z. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127347 · Cited by 8
Raj, N., Fakhri, K. U., Pathak, P., Ahmedi, S., & Manzoor, N. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2294183 · Cited by 12
“The culture was serially diluted 5 fold and 5 m l of each dilution was spotted on YPD agar plates in the absence (control) and presence of test compounds at (MIC and sub-MIC) (Pasrija et al., 2008).”
Wang, L., Jia, Y., Tang, R.-J., Xu, Z. Q., Cao, Y., Jia, X., & Jiang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037768 · Cited by 8
“Depletion of ergosterol or sphingolipids from raft regions impairs Cdr1p-mediated drug transport in a substrate- and cell-type-specific manner [24,25,26].”
BackgroundInsights into the role of sphingolipids in antifungal drug resistance
Kalra, S., Tanwar, S., & Bari, V. K. (2023) · Fungal Biology Reviews · doi:10.1016/j.fbr.2023.100342 · Cited by 8
Fatima, T., Fatima, Z., Billamboz, M., & Hameed, S. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107782 · Cited by 7
Singh, S., Fatima, Z., & Hameed, S. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2020.04.013 · Cited by 7
Singh, S., Hans, S., Ahmad, A., Fatima, Z., & Hameed, S. (2022) · International Microbiology · doi:10.1007/s10123-022-00262-9 · Cited by 6
“The susceptibility of Candida cells to antifungal drugs is also governed by ergosterol and sphingolipid content as the knockout mutants of ergosterol and sphingolipid biosynthetic pathways were susceptible to antifungal drugs such as azoles in comparison to their wild-type strains (Mukhopadhyay et al. 2004; Pasrija et…”
BackgroundKumar, A., Francis, A., Hans, S., & Thakur, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-4909-6_8 · Cited by 7
Tian, Y., Gao, N., Ni, Q., Mao, Y., Dong, D., Huang, X., Jiang, C., Li, Z., Zhang, L., Wang, X., et al. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/foy038 · Cited by 6
Genetically Compromising Phospholipid Metabolism Limits Candida albicans’ Virulence
Wong, D., Plumb, J., Talab, H., Kurdi, M., Pokhrel, K., & Oelkers, P. M. (2019) · Mycopathologia · doi:10.1007/s11046-019-00320-3 · Cited by 6
Banerjee, A., Khandelwal, N., Sanglard, D., & Prasad, R. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00261 · Cited by 5
Self-citationAntifungal Resistance: Cellular and Molecular Mechanisms
Araújo, R., & Espinel‐Ingroff, A. (2010) · Springer eBooks · doi:10.1007/978-3-642-12173-9_7 · Cited by 6
An, L., Huang, X., Zhong, M., Wu, J., Liu, M., Geng, L., Li, Y., Wang, X., Yang, L., & Tan, J. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04230-x · Cited by 5
“This transmembrane protein, characterized by dual transmembrane domains and nucleotide-binding domains (NBDs), facilitates drug efflux through ATP hydrolysis [27–29].”
Eliaš, D., Hervay, N. T., Černáková, L., & Gbelská, Y. (2024) · Journal of Fungi · doi:10.3390/jof10100669 · Cited by 3
Functional analysis of Candida albicans Cdr1 through homologous and heterologous expression studies
Zhao, M., Lamping, E., Niimi, K., Niimi, M., & Cannon, R. D. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf012 · Cited by 3
Hans, S., Fatima, Z., & Hameed, S. (2020) · Current Medical Mycology · doi:10.18502/cmm.6.3.3980 · Cited by 5
“Moreover, the reduction of ergosterol level in Δicl1 could be one of the reasons for the impaired efflux pump activity observed while considering the fact that ABC transporters display different lipid specificities and are targeted to membrane rafts rich in ergosterol [21, 22], which gets depleted in Δicl1 mutant.”
Background
Metadata
- Authors
- Pasrija, R., Panwar, S. L., & Prasad, R.
- Affiliations
- Jawaharlal Nehru University (IN)
- Membrane Biology
- Corresponding author
- Prasad, Rajendra
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2008-02
- Volume
- 52
- Issue
- 2
- Pages
- 694-704
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2224756
- OpenAlex
- W2108097124
- Cited by
- 125
- References
- 49
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 14 · 2023: 5 · 2022: 6 · 2021: 3 · 2020: 12 · 2019: 8 · 2018: 4 · 2017: 7 · 2016: 8 · 2015: 5 · 2014: 5 · 2013: 8 · 2012: 6
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Keywords
- Candida albicans, multidrug transporter, lipid rafts, detergent-resistant membranes, sphingolipids, ergosterol, membrane lipid composition, plasma membrane targeting, drug resistance, major facilitator superfamily, ABC transporters
- MeSH terms
- Antifungal Agents, Candida albicans, Cell Membrane, Ergosterol, Fungal Proteins, Sphingolipids, Membrane Microdomains, Drug Resistance, Fungal, Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.